DP

Devon Park Associates, LLC

Concentrated strategy

Total reported value

$30.8M

Reporting period: 2016-09-30 · Number of holdings: 1

Devon Park Associates, LLC disclosed 1 holdings in its latest 13F filing for the period ending 2016-09-30, with total reported value of $30.8M and a quarterly turnover rate of 24.1%.

Browse other institutions with under $100M AUMBrowse other institutions starting with "D"

Personality snowflake

Concentration
100
Portfolio Stability
24.11
Momentum/Contrarian
50
Sector conviction
0
Diversification
2
Sizing Uniformity

Recent moves

  • Unchanged 45780V102

    0.0% $6.6M

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1Inotek Pharmaceuticals CORPStock-Other100.00%

Holding changes this quarter

Position changes disclosed by Devon Park Associates, LLC for the quarter ending 2016-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1Inotek Pharmaceuticals CORPUnchanged

FAQ

What is Devon Park Associates, LLC and what type of investor is it?
Devon Park Associates, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2016-09-30), the firm manages a tracked equity portfolio valued at approximately $30.8M, spread across 1 disclosed positions.
What are Devon Park Associates, LLC's largest equity positions?
Based on the latest 13F filing, Devon Park Associates, LLC's top holdings by market value are: 1. Inotek Pharmaceuticals CORP — $30.8M (100.0%)
What changes did Devon Park Associates, LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Devon Park Associates, LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Devon Park Associates, LLC focus on?
Sector breakdown data is not yet available for Devon Park Associates, LLC. Check back after the next 13F processing cycle.